# Intent to Sole Source_Quest Diagnostics_De-identified Remnant Nasopharyngeal Specimens Canonical: https://abierto.us/opportunities/202486157 - Solicitation number: 2024-86157 - Notice type: Special notice - Status: Closed. Deadline was May 3, 2024 at 4:00 PM EDT - Department: Department of Health and Human Services - Agency: Centers for Disease Control and Prevention - Contracting office: Centers for Disease Control and Prevention (n-CENTERSFORDISEASECONTROLANDPREVENTION) - NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing - Product or service code: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets - Place of performance: Atlanta, Georgia - County: DeKalb County (FIPS 13089). https://abierto.us/counties/dekalb-county-ga-13089 - City: Atlanta. https://abierto.us/cities/atlanta-ga-1304000 - First posted: April 19, 2024 - Last posted: April 19, 2024 - SAM.gov: https://sam.gov/workspace/contract/opp/c18a70f4561e4a8e870b494859cd966f/view ## Description The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) intends to award a sole source firm fixed price purchase order to Quest Diagnostics for de-identified remnant nasopharyngeal specimens. Quest Diagnostics possesses residual nasopharyngeal specimens from diagnostic testing submitted from across the US public health jurisdiction, a random selection of which can be used as representative inputs for pertussis pathogen genomic surveillance. Additionally, their repository also includes negative specimens from suspected infection that can serve as valuable controls for laboratory assays. Comparable products are not available from other commercial sources in a timely manner and existing surveillance networks fail to recover sufficient numbers of representative specimens. Quest Diagnostics maintains a system for specimen collection and testing that broadly covers the general US population. The CDC will leverage an existing legal partnership to receive proprietary specimens from across the US. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email@cdc.gov by 4:00PM EST May 3, 2024 ## Publications - April 19, 2024: Special notice, due May 3, 2024 at 4:00 PM EDT. Notice c18a70f4561e4a8e870b494859cd966f. https://sam.gov/workspace/contract/opp/c18a70f4561e4a8e870b494859cd966f/view ## Points of contact - Denedra Threatt, DThreatt2@cdc.gov, 14044983371 --- Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/202486157.